Zacks boosts Surgery Partners shares: 4 things to know

Zacks upgraded Nashville, Tenn.-based Surgery Partners shares from a “hold” to a “buy” rating, according to Petro Global News.

Advertisement

Here are four things to know:

1. Zacks’ price target on Surgery Partners shares totals $21.

2. On March 10, 2017, Stifel Nicolaus lowered the company’s rating from a “buy” to a “hold.”

3. Surgery Partners has a one-year low of $11.76 and one-year high of $22.85.

4. The market cap is $967.64 million.

More articles on surgery centers:
SurgCenter Development opens 13th center in Florida; Envision Q4 EBITDA totals $208.7M & more – 6 ASC company notes
4 legislative changes for ASC leaders to note
Banner Health: Tucson ASC, other projects will offset financial setbacks

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.